Personalized Management of Dry Eye Disease: From Pathophysiologic Mechanisms to Targeted Therapeutic Approaches
Addressing the Multifactorial Nature of Dry Eye Disease in Clinical Practice
A Q&A With Douglas K. Devries, OD
Evolving Payer Strategies for Personalized Dry Eye Disease Management
A Q&A With Ryan Haumschild, PharmD, MS, MBA, CPEL
Value-Based Management of Dry Eye Disease: Clinical Insights, Economic Considerations, and Individualized Treatment Strategies
